PATENT CLAIM ANALYSIS

Application Number: 16201481
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["514", "001000"]

Abstract:
The present disclosure in various embodiments teaches methods of treating patients in need of treatment with a Factor Xa inhibitor, and who are also concomitantly administered verapamil.

Claim (Index 20):
The method of  claim 12 , wherein a daily dose of 7.5 mg of rivaroxaban is administered.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 98.0
- Lexical Diversity: 1.07407
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12688038', '13184704', '13454255', '13454286', '13092459']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7373277436735178
- 35 USC 102 Novelty (BERT): 0.5241330662840783
- Combined Prediction Score: 0.7160082759345738
- Mean Citation Score: 231.753408
- Max Citation Score: 234.70894
- Similarity Product: 126.97339759059668

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test